• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • 3 Cosmetics Draft Regulations Issued for Public Consultation

3 Cosmetics Draft Regulations Issued for Public Consultation

Friday, 21 August 2020 / Published in Medical Device, News

3 Cosmetics Draft Regulations Issued for Public Consultation

In July 2020, the NMPA (National Medical Products Administration) announced three drafts and launched a public consultation to solicit comments:

Draft of the administrative measures for cosmetics registration and filing in China

  • The draft was announced on July 21, 2020.
  • The public consultation ends on August 20, 2020.
  • What’s New?
    • The requirements of the registrants and filers have been specified:
      • Well-established QMS (Quality Management System)
      • The person in charge of quality and safety should possess more than 5 years of professional experience in quality management or manufacturing of cosmetics
      • Well-established management system for supplier selection, checking of raw materials upon arrival, manufacturing process, quality control, facility equipment, product inspection, etc.
      • Well-established safety risk assessment, adverse events monitoring, and recall policy for cosmetics
    • The filers should submit the annual report of the products manufactured and imported, as well as the adverse events monitoring report every year to their respective MPA (Medical Products Administration) in China. 
    • During the technical review process, if any false information has been identified in the application submitted, a local or overseas on-site inspection may be required, but subjected to the actual circumstances.

Draft of the classification rules and catalogue

  • The draft was announced on July 29, 2020.
  • The public consultation ends on August 30, 2020.
  • The classification catalogue was drafted in detail according to:
    • Efficacy claims
    • Body parts
    • Product forms
    • Age groups
    • Usage

Draft of the technical guidelines for the safety assessment on cosmetics

  • The draft was announced on July 29, 2020.
  • The public consultation ends on August 30, 2020.
  • Highlights of the draft for the safety assessment procedures of cosmetics include, but not limited to the following:
    • Scope of application
    • Basic Principles and requirements
    • Requirements of the safety assessment inspector
    • Risk evaluation procedures
    • Toxicology of cosmetics
    • Risk evaluation of raw materials
    • Post-market surveillance
    • Safety assessment report

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Public Consultation

What you can read next

NMPA Major Updates Concerning Software as Medical Device (SaMD)
New Regulatory Controls to Support the CSAR Including Animal Testing Exemptions
China special equipment production unit
China special equipment production unit responsibilities – Draft provision for quality and safety issued

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.